VSL#3 Co-Administration Alters Early Obeticholic Acid Exposure in MASLD Mice
VSL#3 Co-Administration Is Associated with Altered Early-Phase Obeticholic Acid Exposure in MASLD Mice
Abstract
VSL#3 co-administration significantly altered early-phase Obeticholic Acid pharmacokinetics in MASLD mice, suggesting potential drug-probiotic interactions.
